Innovations in Implantable Cardiac Monitoring in the COVID-19 Pandemic and Beyond
This webinar will focus on the use of implantable cardiac monitors (ICMs) for the detection of cardiac arrhythmias. We will be sharing our experience of the organisation and coordination of remote monitoring which was a necessity during the COVID-19 pandemic. Furthermore, you will hear about the latest developments in ICMs and the first experience with this new technology in clinical practice: e.g. remote programming, Bluetooth communication with the patient’s smartphone and Reveal LINQ Mobile Manager programmer.
This webinar is supported by::
Welcome and Introductions
Remote monitoring of implantable cardiac monitors: Learnings from the COVID-19 pandemic
Questions and Answers
First experience with the latest innovations in implantable cardiac monitors
Questions and Answers
Summary and Conclusions
Key Learning Objectives
- Understand the learnings on remote monitoring for implantable cardiac monitors from the COVID-19 pandemic and how they could also be implemented post-pandemic
- Learn about the latest innovations in implantable cardiac monitors, how these may lead to clinic efficiency and early arrhythmia diagnosis, and what the early clinical experience is
- Discuss the use of state-of-the-art implantable cardiac monitors in arrhythmia diagnosis
- Cardiac Technicians
- Cardiac Nurses
- Healthcare Professionals involved in diagnosis and monitoring of cardiac arrhythmias
Professor Thomas Pezawas is a cardiologist at the Medical University of Vienna, Austria and his main areas of interest are syncope and cardiac arrhythmias with special focus on catheter ablation, atrial fibrillation, risk stratification for sudden cardiac death and device therapy. He has European Certifications in catheter ablation and device therapy. He served as European Task Force Member and published international guidelines for diagnosis and treatment, led the Arrhythmia Section of the Austrian Society of Cardiology and is Academic Expert in Health Care Management.
Clare Newbery is Lead Physiologist for Cardiac Rhythm Management at University Hospital Southampton, United Kingdom. She specialises in device management and electrophysiology for adult, adult congenital and paediatric patient groups. She has expertise in remote management of cardiac implantable electronic device patients.
Professor Jan Steffel is Vice Chairman and Professor of Cardiology at the University of Zurich, Switzerland where he is also Senior Consultant in Invasive Electrophysiology and Cardiac Devices. He is board certified in Internal Medicine and Cardiology and holds EHRA as well as IBHRE Certification in both Invasive Electrophysiology and Cardiac Devices. His primary research focus is in the field of anticoagulation for stroke prevention in atrial fibrillation as well as novel technologies in cardiac devices.